| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 732737 | Null | 0.0137891122538509 | 0.40352232 |
| NSC 732825 | N1-(4-methoxyphenyl)-4-(1-benzyl-4-chloro-2,5-dioxo-2,5-dihy dro-1H-3-pyrrolylamino)benzamide | 0.0137891122538509 | 0.47240669 |
| NSC 751342 | 12H-Benzo[g]pyrido[2,1-b]quinazoline-4-carboxamide, N-[2(dimethylamino)ethyl]-12-oxo | 0.0137891122538509 | 0.15487843 |
| NSC 756413 | GW876790X | 0.0137891122538509 | -0.23578808 |
| NSC 89671 | Ascotoxin | 0.0137891122538509 | -0.056400992 |
| NSC 129794 | Ethanesulfonic acid, compd. with 2-chloro-5-[4-[m-(4,6-diamino-2,2-dimethyl-s-triazin-1(2H)-yl)phenyl]butyl]benzenesulfonyl fluoride (1:1) | 0.013789112253851 | 0.099334564 |
| NSC 135687 | 5.beta.-Bufa-20,22-dienolide, 14,15.beta.-epoxy-3.beta.,5-dihydroxy-, 3-acetate (8CI) | 0.013789112253851 | 0.4214383 |
| NSC 163424 | 4-Quinazolinamine, 2-[2-(1-pyrrolidinylazo)phenyl]- | 0.013789112253851 | 0.11996539 |
| NSC 173552 | L-Aspartic acid, N-[4-[[(2-amino-4-hydroxy-6-quinazolinyl)methyl]amino]benzoyl]-, monohydrate | 0.013789112253851 | 0.1873078 |
| NSC 244404 | Null | 0.013789112253851 | 0.19271786 |